Articles Referencing AUXL

Zacks.com

Wider Loss at Auxilium, Acquires Actient - Analyst Blog

Auxilium Pharmaceuticals, Inc. ( AUXL ) reported a loss of 12 cents per share in the first quarter of 2013, wider than the year-ago loss of 4 cents and the Zacks Consensus Estimate... Read >>

Benzinga

Mid-Day Market Update: Auxilium Drops On Weak Sales, Conceptus Surges

Midway through trading Monday, the Dow traded up 0.49 percent to 14,784.76 while the NASDAQ gained 0.84 percent to 3,306.75. The S&P also rose, surging 0.58 percent to 1,591.39. Top... Read >>

Zacks.com

Positive Data on BSTC's Xiaflex - Analyst Blog

BioSpecifics Technologies ( BSTC ) recently announced positive top line data from a phase IIa study on Xiaflex for the potential treatment of frozen shoulder syndrome (FSS) in adults.... Read >>

Zacks.com

Actavis Files ANDA for Endo Product - Analyst Blog

Actavis, Inc. ( ACT ) recently announced that it is looking to get its generic version of Endo Health Solutions Inc. 's ( ENDP ) Fortesta (testosterone gel 10mg/0.5g) approved in the... Read >>

Zacks.com

Auxilium Beats on All Fronts - Analyst Blog

Auxilium Pharmaceuticals, Inc. ( AUXL ) reported fourth-quarter 2012 earnings per share of $1.83, well above the year-ago loss of 25 cents and the Zacks Consensus Estimate of $1.71 per... Read >>

Zacks.com

Zacks Rank #5 Additions for Tuesday - Tale of the Tape

Here are 5 stocks added to the Zacks Rank #5 ("strong sell") List today: Accuride Corp. ( ACW ) The Advisory Board Co. ( ABCO ) Allegheny Technologies Inc. ( ATI ) ... Read >>

Zacks.com

Data on Auxilium's Xiaflex - Analyst Blog

Auxilium Pharmaceuticals, Inc. ( AUXL ) recently announced that data from the pivotal phase III trials, IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and... Read >>

Zacks.com

Repros Delays ZA-301 Study Results - Analyst Blog

Repros Therapeutics Inc. ( RPRX ) recently announced that results from the first pivotal study (ZA-301) of Androxal will be declared in the third quarter of 2013 instead of the second... Read >>

Zacks.com

AUXL Files Patent Infringement Suit - Analyst Blog

Auxilium Pharmaceuticals, Inc. ( AUXL ) recently announced the initiation of a patent infringement lawsuit against Upsher-Smith Laboratories, Inc. which is looking to launch its generic... Read >>

Zacks.com

Zacks #5 Rank Additions for Tuesday - Tale of the Tape

Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List today: Alamo Group, Inc. ( ALG ) Asia Entertainment & Resources Ltd. ( AERL ) ASML Holding N.V.... Read >>

Zacks.com

Patent Challenge for Auxilium Pharma - Analyst Blog

Auxilium Pharmaceuticals, Inc. ( AUXL ) and Xstelos Holdings, Inc. ( XTLS ) recently received a notice from Upsher-Smith Laboratories, Inc. regarding the filing of  a 505(b)(2) new... Read >>

Zacks.com

Standard Review for Auxilium's Drug - Analyst Blog

Auxilium Pharmaceuticals, Inc. ( AUXL ) recently announced that the FDA has accepted its supplemental Biologics License Application (sBLA) for Xiaflex (clostridial collagenase for... Read >>

SeekingAlpha

Cadence Pharmaceuticals' Ofirmev Launch Has Gained Traction: Buy

By Smith On Stocks : Investment Background Cadence Pharmaceuticals ( CADX ) achieved the goal of every emerging bio-pharmaceutical company when it received US approval for its first... Read >>

NASDAQ.com News

Pre-Market Earnings Report for July 31, 2012 : BP, ADM, AET, AMG, WTR, BRKR, AVX, AUXL, ACOR, ALLT, CPLP, ABFS

The following companies are expected to report earnings prior to market open on 07/31/2012. Visit our Earnings Calendar for a full list of expected earnings releases. BP p.l.c. ( BP ) is... Read >>

Cabot Heritage Corporation

Happy Fourth of July

Happy Fourth of July! How to Found a Republic Right Fireworks! Auxilium Pharmaceuticals ( AUXL ) is a skyrocket --- The United States has two days every year whose dates say it... Read >>

Displaying 1-15 of 20
<< first < previous 1 2 next > last >>